These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A comparison of the dose-response effects of captopril in anesthetized normotensive and renovascular hypertensive rats. Baranes J; Thiévant P; Le Hegarat M; Delaflotte S; Etienne A; Clostre F; DeFeudis FV Gen Pharmacol; 1982; 13(5):439-43. PubMed ID: 6757046 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol improves vasoprotective effects of captopril on aortic remodeling and fibrosis triggered by renovascular hypertension. Natalin HM; Garcia AF; Ramalho LN; Restini CB Cardiovasc Pathol; 2016; 25(2):116-9. PubMed ID: 26764145 [TBL] [Abstract][Full Text] [Related]
10. Differentiation between renovascular and essential hypertension by means of changes in single kidney 99mTc-DTPA clearance induced by angiotensin-converting enzyme inhibition. Pedersen EB; Jensen FT; Eiskjaer H; Hansen HH; Jensen JD; Jespersen B; Madsen B; Nielsen HK; Sørensen SS Am J Hypertens; 1989 May; 2(5 Pt 1):323-34. PubMed ID: 2655658 [TBL] [Abstract][Full Text] [Related]
11. The effect of angiotensin II receptor antagonists on kidney function in two-kidney, two-clip Goldblatt hypertensive rats. Abdi A; Johns EJ Eur J Pharmacol; 1997 Jul; 331(2-3):185-92. PubMed ID: 9274978 [TBL] [Abstract][Full Text] [Related]
13. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785 [TBL] [Abstract][Full Text] [Related]
14. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme. DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478 [TBL] [Abstract][Full Text] [Related]
15. Dissociation between in vivo and in vitro measurements of converting enzyme activity after chronic oral treatment with captopril in rats. Unger T; Hübner D; Schüll B; Yukimura T; Rascher W; Lang RE; Ganten D Am J Cardiol; 1982 Apr; 49(6):1530-2. PubMed ID: 6280482 [TBL] [Abstract][Full Text] [Related]
16. Myocardial effect of converting enzyme inhibition in hypertensive and normotensive rats. Michel JB; Salzmann JL; Cerol ML; Dussaule JC; Azizi M; Corman B; Camilleri JP; Corvol P Am J Med; 1988 Mar; 84(3A):12-21. PubMed ID: 2975459 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat. DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481 [TBL] [Abstract][Full Text] [Related]
18. Responses of blood pressure and angiotensin-converting enzyme activity to acute captopril administration in normotensive and hypertensive rats. Levens NR; Peach MJ; Vaughan ED; Weed WC; Carey RM Endocrinology; 1981 Feb; 108(2):536-44. PubMed ID: 6256155 [TBL] [Abstract][Full Text] [Related]
19. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension]. Posadzy-Małaczyńska A Przegl Lek; 1997; 54(5):314-9. PubMed ID: 9380805 [TBL] [Abstract][Full Text] [Related]
20. Central angiotensin converting enzyme blockade and salt preference in renovascular hypertensive rats. Chan JY; Hutchinson JS Ann Acad Med Singap; 1985 Jan; 14(1):137-42. PubMed ID: 2988403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]